Movement Alert|Semtech Rises 6.13% in Regular Trading, LoRa Plus Product Line Expansion Combined with UBS Buy Rating Ahead of Earnings

Market Focus
Aug 21

On August 21, Semtech rose 6.13% in regular trading, trading at $128.82/share, with turnover of $21.57 million.

On the news front, the company announced on August 19 the expansion of its flagship LoRa Plus chip product line, with LR2022 and LR2012 transceivers officially entering mass production. Together with the previously launched LR2021, these products form a complete three-chip matrix covering Sub-GHz to satellite-direct multi-band frequencies, addressing diverse IoT deployment scenarios from basic sensors to satellite connectivity and edge AI. Additionally, UBS analyst Timothy Arcuri reiterated a Buy rating with a $225 target price ahead of the company's earnings report scheduled for August 25, citing expectations that data center revenue will climb strongly and overall revenue will approach the high end of guidance, with EPS potentially reaching approximately $0.70 for the October quarter.

Further supporting sentiment, Semtech previously signed a definitive agreement to sell its cellular module business to Compal Electronics for $62 million in cash and secured a $360 million revolving credit facility, reinforcing strategic focus and financial flexibility.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10